IndraLab

Statements


| 2

reach
"Parthenolide inhibits the MyD88 dependent pathway by inhibiting the activity of inhibitor-kappaB kinase."

reach
"Other signaling inhibitors including antiapoptotic protein A20, agonistic lipid A and its analogues, inhibitors of IkB2, salicylate and parthenolide, NF-B kinases inhibitor PS-1145, inhibitors of p38, JNK, anti-TLR, anti-MyD88 antibodies, are able to target the TIR domain of the TLR4 or the MyD88 [XREF_BIBR, XREF_BIBR, XREF_BIBR]."